MLF2 siRNA Oligos set (Human)
MLF2 CRISPR
MLF2 Lentiviral
MLF2 AAV
MLF2 Adenovirus
MLF2 ORF
MLF2 siRNA
-
Retired Cat.No.
30189171 -
Product Name
MLF2 siRNA Oligos set (Human) -
Unit
4 x 5 nmol -
Gene Name/Gene ID
MLF2, -2 -
Gene Full Name
myeloid leukemia factor 2 -
Alias
NTN4 -
Accession Number
-
Species
Human -
System
siRNA oligos -
Target Sequence
Sequence available upon placing order -
Storage Condition
Upon receipt, -70°C for long term storage; -20°C for short term storage.
Recommended storage concentration is above 20μM.
After reconstitution, store in aliquots to avoid repeated freeze-thawing. -
Disclaimer
1. Disclaimer for accession number: The provided accession number refers to the transcript (mRNA) sequence the siRNA product targets. Please verify that this is the desired transcript sequence by cross-referencing. This is important because a single gene can have multiple different transcripts owing to naturally occurring variations. All sales are final. 2. Disclaimer for intended use: All of abm's vectors and viral particles are for research use ONLY and NOT for therapeutic/diagnostic applications. abm is not liable for any repercussions arising from the use of its vector(s) in therapeutic/diagnostic application(s). 3. Disclaimer for extra nucleotides: Cloning may lead to the insertion of extra nucleotides at the 5' or 3' end of the target sequence which, in most cases, is innocuous to the stability/functionality of the construct. -
Guarantee
abm guarantees that at least one out of the three siRNA oligos purchased in a set will result in over 70% knockdown of gene expression (qPCR) within target cells showing >50% transfection efficiency. If this is not the case, we will provide a one-time replacement of three new constructs with alternative siRNA sequences. To qualify for this replacement, the oligos must be transfected at the appropriate amounts (see Troubleshooting section of the User Manual) and assayed at least 48 hours post-transfection. Customers must provide adequate data to show >50% transfection efficiency with a positive control, plus additional qPCR data to evaluate the level of gene expression. The replacement set will not covered by the same guarantee, and if these constructs are also considered to be ineffective then it is most likely the gene is not susceptible to siRNA knockdown. abm limits its obligation and liability for the success of this technology to providing one replacement of any siRNA oligo product only. Before sending your inquiry, please make sure you have optimized your experiments as far as possible, this includes (where applicable) optimizing the siRNA concentration and the duration of transfection (up to 72 hours). Please send all replacement inquiries and experimental data to technical@abmgood.com -
Caution
This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. -
Promotions
Free controls included with every siRNA oligo order:
1 x 2.5nmol (1 OD duplex) of positive control siRNA
1 x 2.5nmol (1 OD duplex) of negative control siRNA
1 x 2.5nmol (1 OD duplex) of FAM-labeled negative control siRNA
Print/Download Datasheet
Search CoA here
Supporting Protocol
Publishing research using PS130189? Please let us know so that we can cite the reference in this datasheet.
PS130189 has not been cited in any literature.
Question
ABM community
Verified customer
Asked on Jan 30 2026
Answer
The lentivirus should be aliquoted into smaller working volumes and then stored at -80°C. Lentivirus is sensitive to storage temperature and to freeze/thaws. It can lose up to 5% or more activity with each freeze/thaw. When stored properly, viral stocks of an appropriate titer should be suitable for use for up to one year. After long-term storage, we recommend re-titering your viral stocks before use.
ABM Scientific Support
Answered on Jan 30 2026
ABM community
Verified customer
Asked on Jan 30 2026
Answer
abm lentiviral transfer vectors use the third generation lentivirus system. It is based on the inactivated HIV genome. Note that our lentivirus packaging plasmids cannot be integrated into the host and are transiently expressed.
ABM Scientific Support
Answered on Jan 30 2026
ABM community
Verified customer
Asked on Mar 24 2025
Answer
We recommend using abm’s 2nd Generation Packaging System Mix (Cat. No. LV003) or 3rd Generation Packaging System Mix (Cat. No. LV053). abm’s lentiviral vectors have been tested and are compatible with Invitrogen’s packaging mix; we have not tested other suppliers and cannot guarantee compatibility.
ABM Scientific Support
Answered on Mar 24 2025
ABM community
Verified customer
Asked on Mar 24 2025
Answer
Higher MOI will provide more copies of the antibiotic resistance gene per cell. Cells containing multiple copies of the resistance gene can withstand higher antibiotic concentrations compared to those at lower MOIs. The concentration of antibiotic should be adjusted to a level that will cause selection for the desired population of transduced cells without going below the minimum antibiotic concentration you have established in your killing curve.
ABM Scientific Support
Answered on Mar 24 2025
ABM community
Verified customer
Asked on Jan 30 2026
Answer
MOI (Multiplicity of Infection) refers to the number of viral particles per cell used in the infection, e.g. an MOI of 5 indicates that there are five infectious units (IU) or transducing units (TU) for every cell. MOI is determined by calculating the numbers of viral particles added per well then divide this number by the number of cells seeded into the well. We also recommend transducing the cells with a range of MOIs as different cell types may require different MOIs for successful transduction.
MOI = Product Titer (IU/ml) x Virus Volume (ml) / Total Cell Number
MOI = Product Titer (IU/ml) x Virus Volume (ml) / Total Cell Number
ABM Scientific Support
Answered on Jan 30 2026
ABM community
Verified customer
Asked on Jan 30 2026
Answer
The concentration must be optimized for each cell type. Typical selection amounts are around 0.1 - 0.5µg per ml.
ABM Scientific Support
Answered on Jan 30 2026
ABM community
Verified customer
Asked on Mar 24 2025
Answer
Yes.
ABM Scientific Support
Answered on Mar 24 2025
ABM community
Verified customer
Asked on Mar 24 2025
Answer
Our scramble negative control can be used for human, mouse and rat. Please refer to abm’s Control Vectors and Viruses webpage for a full list.
ABM Scientific Support
Answered on Mar 24 2025
ABM community
Verified customer
Asked on Mar 24 2025
Answer
We recommend testing all 4 siRNA vectors. abm guarantees that at least one out of the four vector constructs purchased in a set will result in over 70% knockdown of gene expression within target cells showing >80% transfection efficiency.
ABM Scientific Support
Answered on Mar 24 2025
ABM community
Verified customer
Asked on Mar 24 2025
Answer
These vectors contain siRNAs. We employ a dual convergent promoter system where the sense and antisense strands of the siRNA are expressed by two different promoters rather than in a hairpin loop – this is to avoid any possible recombination events that can occur.
ABM Scientific Support
Answered on Mar 24 2025
Prev
Next
There are currently no reviews for PS130189.
Please use the link above to contact us or submit feedback about this product.
×
Current vector selected:
MLF2 siRNA Oligos set (Human)
Cat. No.
PS130189
Plasmid DNA Services
Upgrade to shRNA
1 Service
$150.00
Midiprep Plasmid Amplification (Add-on)
10-20 µg
$75.00
Maxiprep Plasmid Amplification (Add-on)
80-100 µg
$150.00
Bacterial Agar Stab (Add-on)
1 stab
$40.00
Controls and Related Products
DNAfectin™ Plus Transfection Reagent
G2500
1.0 ml
$245.00
Empty
×
Current vector selected:
MLF2 siRNA Oligos set (Human)
Cat. No.
PS130189
Controls and Related Products
DNAfectin™ Plus Transfection Reagent
G2500
1.0 ml
$245.00
Empty
×
The vector and the related service will be deleted together.
×
Add the Blank Control Vector to cart?